As of June 12, 2018 our Privacy Policy has been updated. For individuals in the European Union, CIL uses cookies on this website. Please review the new privacy statement to see how. By continuing to use this website you agree to us using cookies in accordance with our privacy statement. Click here for the new privacy statement..OK

Deuterated Reagents for Pharmaceuticals

Deuterated Reagents for Pharmaceuticals

Stable Isotope-Labeled Synthetic Intermediates

In recent years, some pharmaceutical companies have begun to investigate deuteration of molecules that may provide advantages over their existing nondeuterated counterparts. In addition, increasing research into the potential medical advantages of new deuterated drugs is also occurring.

Application | Cambridge Isotope Laboratories, Inc.